Analysen von Matthew Weston
| 24.04.24 | Roche Neutral | UBS AG | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | Roche Neutral | UBS AG | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | Sartorius vz. Neutral | UBS AG | |
| 17.04.24 | Sartorius vz. Neutral | UBS AG | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 09.04.24 | Roche Neutral | UBS AG | |
|
Werbung
|
|||
| 05.04.24 | AstraZeneca Sell | UBS AG | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 26.03.24 | Merck Buy | UBS AG | |
| 25.03.24 | AstraZeneca Sell | UBS AG | |
| 20.03.24 | Roche Neutral | UBS AG | |
| 19.03.24 | AstraZeneca Sell | UBS AG | |
| 14.03.24 | Sartorius vz. Neutral | UBS AG | |
| 07.03.24 | Merck Buy | UBS AG | |
| 26.02.24 | Merck Buy | UBS AG | |
| 22.02.24 | Roche Neutral | UBS AG | |
| 19.02.24 | AstraZeneca Sell | UBS AG | |
| 09.02.24 | AstraZeneca Sell | UBS AG | |
| 08.02.24 | AstraZeneca Sell | UBS AG | |
| 06.02.24 | Novartis Buy | UBS AG | |
| 05.02.24 | Roche Neutral | UBS AG | |
| 01.02.24 | Roche Neutral | UBS AG | |
| 31.01.24 | Novartis Buy | UBS AG | |
| 31.01.24 | AstraZeneca Sell | UBS AG | |
| 31.01.24 | Roche Neutral | UBS AG | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 29.01.24 | Sartorius vz. Neutral | UBS AG | |
| 25.01.24 | Sartorius vz. Neutral | UBS AG | |
| 16.01.24 | AstraZeneca Sell | UBS AG | |
| 15.01.24 | Merck Buy | UBS AG | |
| 15.01.24 | Sartorius vz. Neutral | UBS AG | |
| 15.01.24 | Roche Neutral | UBS AG | |
| 15.01.24 | Novartis Buy | UBS AG | |
| 18.04.23 | Sartorius vz. Neutral | Credit Suisse Group | |
| 07.06.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 06.08.21 | Merck Outperform | Credit Suisse Group | |
| 14.12.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 06.11.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 16.10.20 | Roche Neutral | Credit Suisse Group | |
| 08.10.20 | Roche Neutral | Credit Suisse Group | |
| 24.07.20 | Roche Neutral | Credit Suisse Group | |
| 15.05.20 | Merck Outperform | Credit Suisse Group | |
| 23.04.20 | Roche Neutral | Credit Suisse Group | |
| 18.02.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 25.11.19 | Novartis Neutral | Credit Suisse Group | |
| 29.10.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 25.04.19 | Novartis Neutral | Credit Suisse Group | |
| 05.04.19 | Novartis Neutral | Credit Suisse Group | |